...
首页> 外文期刊>Circulation journal >Positive pressure ventilation treatment reduces plasma levels of amino terminal-pro brain natriuretic peptide in congestive heart failure patients with sleep apnea.
【24h】

Positive pressure ventilation treatment reduces plasma levels of amino terminal-pro brain natriuretic peptide in congestive heart failure patients with sleep apnea.

机译:正压通气治疗可降低充血性心力衰竭伴睡眠呼吸暂停患者的氨基末端脑钠肽的血浆水平。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The purpose of the present study was to assess the short-term effects of positive pressure ventilation (PPV) on plasma amino terminal-pro brain natriuretic peptide (NT-proBNP) levels in patients with congestive heart failure (CHF) and sleep apnea (SA). METHODS AND RESULTS: Polysomnography was performed in 105 CHF patients. Twenty-six patients with CHF and SA were randomly assigned to a control group or a PPV group. Patients in the higher New York Heart Association classes had higher plasma levels of NT-proBNP. The plasma NT-proBNP concentration in the PPV group decreased. CONCLUSION: Plasma NT-proBNP levels reflect the severity of CHF, and PPV can decrease plasma NT-proBNP levels in patients with CHF and SA.
机译:背景:本研究的目的是评估充血性心力衰竭(CHF)和睡眠呼吸暂停患者正压通气(PPV)对血浆氨基末端-脑钠肽(NT-proBNP)水平的短期影响(SA)。方法与结果:对105名CHF患者进行了多导睡眠监测。将26例CHF和SA患者随机分为对照组或PPV组。纽约心脏协会等级较高的患者的血浆NT-proBNP水平较高。 PPV组的血浆NT-proBNP浓度降低。结论:血浆NT-proBNP水平反映了CHF的严重程度,PPV可以降低CHF和SA患者的血浆NT-proBNP水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号